Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2021 09:01 ET | Source: Biofrontera AG

Biofrontera AG announces initiation of clinical studies

Leverkusen, Germany, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that two...
October 01, 2021 07:44 ET | Source: Biofrontera AG

Biofrontera reports preliminary approximate revenues for the month of September 2021

Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
July 06, 2021 17:59 ET | Source: Biofrontera AG

Biofrontera Inc. seeks IPO in the USA

Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG currently holds 100 % of the shares of the US-based Biofrontera Inc. Biofrontera AG had already announced that opportunities...
June 22, 2021 09:00 ET | Source: Biofrontera AG

Biofrontera provides update on clinical developments

Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an...
May 11, 2021 10:41 ET | Source: Biofrontera AG

Biofrontera reports Q1 2021 financial results

Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
May 06, 2021 07:23 ET | Source: Biofrontera AG

Biofrontera reports preliminary revenue for the month of April 2021

Leverkusen, Germany, May 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
May 03, 2021 09:40 ET | Source: Biofrontera AG

Biofrontera AG: First quarter conference call to be held on May 12, 2021

Leverkusen, Germany, May 03, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its ...
April 12, 2021 13:57 ET | Source: Biofrontera AG

Biofrontera reports results for the 2020 financial year

Leverkusen, Germany, April 12, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
April 08, 2021 10:30 ET | Source: Biofrontera AG

Biofrontera announces preliminary revenue for Q1 2021

Leverkusen, Germany, April 08, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
March 31, 2021 10:12 ET | Source: Biofrontera AG

Biofrontera announces conference call to be held on April 13, 2021 to discuss fiscal year 2020 financial results

Leverkusen, Germany, March 31, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...

Next Page keyboard_arrow_right